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ing cause of cancer death in males in 2008 globally.
Aim of the work: To evaluate the clinico-pathological proﬁle of the bronchogenic carcinoma
cases in the Chest Department, Cairo University.
Patients and methods: Retrospective study was carried out in the Chest Department, Cairo Uni-
versity, in which four hundred and four conﬁrmed cases of bronchogenic carcinoma were admitted
during July 2002 till July 2012. Data regarding demographics, smoking, histology, clinical presen-
tation, radiographic ﬁndings are reported.
Results: Our study included 404 conﬁrmed cases of bronchogenic carcinoma. Male to female
ratio was 4.6:1. The highest incidence was in the sixth and seventh decades of life (63.6%). Smoking
was found to be the main risk factor in 75.7% of patients. Cough was the most common symptom
found in 347 patients (85.9%), followed by dyspnea in 276 patients (68.3%). Most common radio-
logical ﬁnding was mass lesion (49.8%). Majority of cases were diagnosed by bronchoscopy
(68.1%). Four types of bronchogenic carcinoma were found: squamous cell carcinoma 37.4% ade-
nocarcinoma 29.5%, small cell carcinoma 14.9%, large cell carcinoma 7.2% and undifferentiated
carcinoma 11.1%. In females, adenocarcinoma was the predominant cell type (54.2%) while in
males, squamous cell carcinoma was the predominant cell type (42.5%).24109776.
(I.M. Sabry).
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706 Y.M. Akl et al.Conclusion: Bronchogenic carcinoma is more frequent beyond the middle age. Smoking is still
the major risk factor. Adenocarcinoma is more common in females and was the most frequent
tumor in non-smokers, while in males, squamous cell carcinoma is still the predominant cell type.
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cases.
Sex Frequency (No.) Percentage Ratio
Male 332 82.2 4.6
Female 72 17.8 1.0
Total 404 100.0 4.6:1Introduction
At the end of the 20th century, Bronchogenic Carcinoma had
become one of the leading causes of preventable death. It was a
rare disease at the start of that century, but exposures to new
etiologic agents and an increasing life span combined to make
lung cancer a scourge of the 20th century. Lung cancer is the
most common malignancy worldwide and is the leading cause
of cancer deaths in men and women [1].
Lung cancer was the most commonly diagnosed cancer as
well as the leading cause of cancer death in males in 2008
globally. Among females, it was the fourth most common
diagnosed cancer and the second leading cause of cancer
death. Lung cancer accounted for 13% (1.6 million) of the
total cases and 18% (1.4 million) of the death in 2008 [2].
Patients and methods
This retrospective study was carried out in the Department of
Chest Medicine of Cairo University Hospital, in which four
hundred and four (404 cases) histopathologically and/or
cytologically conﬁrmed cases of bronchogenic carcinoma were
included in the study. These patients were admitted during the
last 10 years (from 2001 to 2010).
Data regarding demographics (age of the patients, sex),
smoking status, histopathological type, clinical presentation,
radiographic ﬁndings, the method of diagnosis and clinical
stage of the disease were obtained from the ﬁles of conﬁrmed
cases of bronchogenic carcinoma.
Radiological assessment was done in all cases. The
diagnosis of bronchogenic carcinoma was based on positive
histopathological or cytological examination. Patients without
histopathological conﬁrmation were excluded from this study.
For conﬁrmation of diagnosis of bronchogenic carcinoma,
majority of patients were subjected to ﬁbro-optic bronchos-
copy and/or CT-guided biopsy. Other diagnostic methods were
open biopsy, thoracoscopy, pleural ﬂuid and supraclavicular
lymph node biopsy.
All case data were tabulated. Statistical analysis was
performed using descriptive statistics of the collected data.Results
The results are shown in Tables 1–10 and Figs. 1–9.
Discussion
Accurate epidemiological data on lung cancer in Egypt are not
available since a comprehensive national population-based
cancer registry is lacking. However, ofﬁcial statistics as well
as institution and hospital-based studies show that it is the
second most common cancer in men and second leading cause
of cancer death, after bladder cancer [3].
As regards to the sex distribution of bronchogenic
carcinoma cases, Table 1 shows that 82.2% of cases were males
and 17.8% of cases were females with a male to female ratio of
4.6:1 which is near to that reported by Elattar from the
National Cancer Institute (NCI) in Egypt [3]. According to
Bahader and Jazieh study the male:female ratio was 3:1 [4].
In many of the more developed countries, the incidence of
lung cancer in men has reached a plateau and is now
decreasing, whereas the number of new cases in women contin-
ues to increase [5,6].
According to Devesa et al., male:female rate ratios varied
from less than 2 in Iceland, US whites, Canada, Denmark
and Sweden to more than 6 in Slovenia, Italy, and France
and more than 10 in Spain [7].
Generally, lung cancer trends among females lag behind
males lung cancer rates in females are increasing in many
countries [2]. In recent years, adenocarcinoma has increased
as a proportion of all lung cancers diagnosed [8]. Women are
Table 2 Mean age of incidence in males and females and in both sexes.
Sex No. Minimum Maximum Mean Std. Deviation
Male 332 26 90 58.50 10.98
Female 72 35 75 53.42 8.92
Total 404 36 90 57.54 10.81
Table 3 Relation between age groups and histological cell type.
Age group SCC No. SCLC No. Adeno CA No. LCC No. Undiﬀ. No.
26–40 5 (3.3%) 3 (5.0%) 8 (6.7%) 4 (13.8%) 4 (8.9%)
41–50 19 (12.6%) 22 (36.7%) 34 (28.6%) 11 (37.9%) 6 (13.3%)
51–60 42 (27.8%) 20 (33.3%) 42 (35.3%) 5 (17.2%) 19 (42.2%)
61–70 70 (46.4%) 15 (25.0%) 26 (21.8%) 6 (20.7%) 12 (26.7%)
>70 15 (9.9%) 0 (0.0%) 9 (7.6%) 3 (10.3%) 4 (8.9%)
Total 151 (100%) 60 (100%) 119 (100%) 29 (100%) 45 (100%)
Table 4 Incidence of different histopathologic cell types in smokers and in non-smokers.
Histopathological cell type Smoking status Total
Smoking Non-smoking No. %
No. % No. %
Squamous cell carcinoma 134 88.7 17 11.3 151 37.4
Small cell carcinoma 49 81.7 11 18.3 60 14.9
Adenocarcinoma 63 52.9 56 47.1 119 29.5
Large cell carcinoma 26 89.7 3 10.3 29 7.2
Undiﬀerentiated carcinoma 34 75.6 11 24.4 45 11.1
Total 306 75.7 98 24.3 404 100
Table 5 Distribution of histopathological cell types according to the radiological ﬁndings.
Histopathologic cell type Lung mass Apical opacity Pleural eﬀusion Hilar mass Cavitary lesion Pulmonary nodule Total
Squamous cell carcinoma 67 (44.4%) 25 (16.6%) 11 (7.3%) 38 (25.2%) 9 (6.0%) 1 (0.7%) 151 (100%)
Small cell carcinoma 40 (66.7%) 3 (5.0%) 2 (3.3%) 11 (18.3%) 2 (3.3%) 2 (3.3%) 60 (100%)
Adenocarcinoma 64 (53.8%) 10 (8.4%) 25 (21.0%) 11 (9.2%) 7 (5.9%) 2 (1.6%) 119(100%)
Large cell carcinoma 15 (51.7%) 2 (6.9%) 6 (20.7%) 2 (6.9%) 3 (10.3%) 1 (3.4%) 29 (100%)
Undiﬀerentiated carcinoma 15 (33.3%) 13 (28.9%) 5 (11.1%) 2 (4.4%) 9 (20%) 1 (2.2%) 45 (100%)
201 (49.8%) 53 (13.1%) 49 (12.1%) 64 (15.8%) 30 (7.4%) 7 (1.7%) 404
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explain the narrowing of the gap between men and women in
the incidence of bronchogenic carcinoma in our study.
Studying the age distribution in this work shows that, the
highest incidence of bronchogenic carcinoma was in the sixth
and seventh decades of life with 63.6% of the cases found in
these two decades of life (Fig. 1).
The incidence declined before the age of 40 with 5.9% of
cases and after the age of 70 with 7.7% of cases, and no cases
were found before age of 26 years, indicating that broncho-
genic carcinoma was less common in these age groups.
Similarly, a study carried out by Karlikaya and Cakir Edis
[9] and another study by Suliman et al. [10] also proved that
maximum patients were in their sixth and seventh decade at
the time of diagnosis of bronchogenic carcinoma.The average age at the time of diagnosis that was reported
by the Radzikowska study was 61.94 years [11]. In our study,
age ranged from 26 to 90 years with 58.59 years being the
average age (Table 2). This may be explained by that patients
started smoking early in their life. The mean age in males was
58.50 years and it was 53.42 years in females.
The relation between age groups and histological cell type
(Table 3) shows that the squamous cell carcinoma was
common after the age of 50 years (84.1%) while the small cell
carcinoma was common in the age period between 40 and
60 years (70%) and also adenocarcinoma cell type was com-
mon in the age period between 40 and 60 years (63.9%).
As regards to smoking status, there have been many studies
in many parts of the world which showed a relationship
between smoking and bronchogenic carcinoma. In our study,
Table 6 Different cell types of cases that present with pleural
effusion.
Cell type No. and % of cases present
with pleural eﬀusion
Squamous cell carcinoma 11 22.4%
Small cell carcinoma 2 4.1%
Adenocarcinoma 25 51%
Large cell carcinoma 6 12.2%
Undiﬀerentiated carcinoma 5 10.2%
Total 49 100%
Table 7 Different cell types of cases that present with hilar
shadow.
Cell type No. and % of cases present
with hilar shadow
Squamous cell carcinoma 38 59.4%
Small cell carcinoma 11 17.2%
Adenocarcinoma 11 17.2%
Large cell carcinoma 2 3.1%
Undiﬀerentiated carcinoma 2 3.1%
Total 64 100%
Table 8 Different methods of diagnosis of bronchogenic
carcinoma and their percentages.
Methods of diagnosis No. %
FOB 275 68.1
CT guided biopsy 86 21.3
Supraclavicular LN biopsy 2 0.5
Pleural ﬂuid 9 2.2
Thoracoscopy 15 3.7
Open biopsy 17 4.2
Total 404 100
708 Y.M. Akl et al.smoking habit of the patient (Fig. 2), revealed that, the number
of smokers (75.7%) is 3 folds that of non-smokers (24.3%).
Study of Rawat et al., reported that smoking was the main risk
factor in 81.77% patients [12].
In our study of 72 females with bronchogenic carcinoma, a
high percentage of them were non-smokers (97.25% non-
smokers versus 2.8% smokers). And this explains the relatively
high percentage (42.3%) of non-smokers in our study.
In male cases, the percentage of smokers was 91.6% while
the percentage of non-smokers was 8.4% of male (Fig. 3).
In our study, the percentage of non-smoking females was
97.2% versus only 2.8% of smoking females, so other risk fac-
tors other than smoking, should be considered that include
exposure to environmental tobacco smoke (ETS), fumes and
smoke from certain cooking fuels and environmental
pollution.
In our study smoking is associated with all types of bron-
chogenic carcinoma. The connection between smoking and
bronchogenic carcinoma was most evident among patients
with squamous cell carcinoma, small cell carcinoma and large
cell carcinoma and less evident among patients with adenocar-
cinoma (Fig. 4).The strength of the association between cigarette smoking
and bronchogenic carcinoma varies by cell type, with the
largest for squamous and small cell carcinomas and somewhat
smaller for adenocarcinoma. This result is similar to that
reported in another study [13].
The different clinical presentations of the patients (Fig. 5)
revealed that cough was the most frequent symptom in the
whole group, as 347 patients (85.9%) had this complaint.
According to Rawat et al. study cough was the common
symptom (72.90%) [12].
Cough is present in >65% of patients at the time lung
cancer is diagnosed [14].
In this study cough was the most common symptom (347
patients; 85.9%) and was followed by dyspnea (276 patients;
68.3%), expectoration (270 patients; 66.8%), chest pain (241
patients; 59.7%), hemoptysis (142 patients; 35.1%) weight loss
(115 patients; 28.5%), and hoarseness of voice (85 patients;
21%) was also a frequent symptom. Other symptoms, as fever
(16.3%), dysphagia (9.2%) and supraclavicular lymph node
(1%) were not so frequent clinical presentations. In our study
the incidence of symptoms was high compared to those
described in the literature (Fig. 5) and this explained by that
our patients presented late in their disease.
The radiological ﬁndings (Fig. 6), showed that, lung mass
was the commonest radiological picture, as it occurred in
201 cases (49.8%) near to that percentage (46.31%) that was
reported by Rawat et al. study [12] followed by hilar shadow
(15.8%), apical opacity (13.1%),and pleural effusion (12.1%).
Cavitary lesion was found in 7.4% of cases. A prospective
study by Shetty et al., found that cavitary lesion incidence was
8.6% of lung cancer [15]. Pulmonary nodule in our study
occurred in 1.7% of cases, this may be explained by that most
cases were presented in late stages.
Distribution of histopathologic cell types according to the
radiological ﬁndings (Table 5), showed that 44.4% of cases
of squamous cell carcinoma presented with mass lesion
followed by 25.2% of cases presented with hilar shadow and
16.6% presented radiologically with apical opacity while
pleural effusion and cavitary lesion presented in 7.3% and
6% of the squamous cell carcinoma cases, respectively.
In our study, 53.8% of cases of adenocarcinoma presented
with mass lesion followed by 21% of cases of adenocarci-
noma presented with pleural effusion while hilar shadow
incidence was 9.2% of adenocarcinoma cases. Most of cases
of small cell carcinoma presented radiologically with mass
lesion 66.7% followed by hilar shadow in 18.3% of small cell
carcinoma cases. 51.7% of large cell carcinoma presented
with mass lesion and 20.7% of large cell carcinoma with
pleural effusion.
In all cell types of bronchogenic carcinoma, the mass lesion
was the major radiological picture, in this study (Fig. 8).
Table 6 shows that pleural effusion was more frequent with
adenocarcinoma, as 51% of cases that presented with pleural
effusion were adenocarcinoma and this may be due to that
most of adenocarcinoma located peripherally and it can cause
pleural invasion.
Table 7 shows that hilar shadows were common with
squamous cell carcinoma, as 59.4% of cases presented with
hilar shadows were squamous cell carcinoma followed by small
cell carcinoma and adenocarcinoma (17.2%).
Apical opacity incidence was more frequent with squamous
cell carcinoma, 47.2% of cases that presented with apical
Table 10 Stage of disease.
Stage Frequency (No.) Percentage
Operable stage 11 9.8
Inoperable stage 101 90.2
Total 112 100.0
Figure 1 Age distribution of the bronchogenic carcinoma cases.
Figure 2 Incidence of bronchogenic carcinoma in smokers and
in non-smokers.
Table 9 Distribution of bronchogenic carcinoma cell types according to the method used for diagnosis.
Diagnosis method Histopathology Total
SCC SCLC Adeno-CA LCC Undiﬀ
FOB Count 107 52 60 21 35 275
% within diagnosis method 38.9 18.9 21.8 7.6 12.7 100.0
% within histopathology 70.9 86.7 50.4 72.4 77.8 68.1
CT guided biopsy Count 36 5 38 3 4 86
% within diagnosis method 41.9 5.8 44.2 3.5 4.7 100.0
% within histopathology 23.8 8.3 31.9 10.3 8.9 21.3
Supraclavicular LN biopsy Count 0 1 0 0 1 2
% within diagnosis method 0.0 50.0 0.0 0.0 50.0 100.0
% within histopathology 0.0 1.7 0.0 0.0 2.2 0.5
Pleural ﬂuid Count 2 0 3 4 0 9
% within diagnosis method 22.2 0.0 33.3 44.4 0.0 100.0
% within histopathology 1.3 0.0 2.5 13.8 0.0 2.2
Thoracoscopy Count 2 0 9 1 3 15
% within diagnosis method 13.3 0.0 60.0 6.7 20.0 100.0
% within histopathology 1.3 0.0 7.6 3.4 6.7 3.7
Open biopsy Count 4 2 9 0 2 17
% within diagnosis method 23.5 11.8 52.9 0.0 11.8 100.0
% within histopathology 2.6 3.3 7.6 0.0 4.4 4.2
Total Count 151 60 119 29 45 404
% within diagnosis method 37.4 14.9 29.5 7.2 11.1 100.0
% within histopathology 100.0 100.0 100.0 100.0 100.0 100.0
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undifferentiated carcinoma.
Table 8 and Fig. 7 illustrate different methods of diagnosis
that had been performed in this study, in our study, diagnosis
of bronchogenic carcinoma was made by ﬁbreoptic bronchos-
copy in 275 patients (68.1%), and this percentage is near to
that reported in another study which was 61.7% [16]. An
important role in improving the diagnostic relevance of the
ﬁbreoptic bronchoscopy was assumed by the more frequent
adoption of biopsies and trans-bronchial needle aspiration
on parenchyma and mediastinal lymph nodes.Table 9 shows that bronchoscopic biopsy was positive in
107 of 151 patients (70.9%) of the squamous cell carcinoma
cases, also in 52 of 60 patients (86.7%) of cases of the small cell
carcinoma, in 60 of 119 patients (50.4%) of cases of adenocar-
cinoma, in 21 of 29 patients (72.4%) of cases of the large cell
carcinoma and. in 35 of 45 patients (68.1%) of cases of
undifferentiated carcinoma.
The cases of bronchogenic carcinoma that was diagnosed
by CT guided biopsy were 86 cases (21.3% of all cases). Table 9
shows that most cases that were diagnosed by FNAB (FNAB
done under CT) was adenocarcinoma (38 patients; 44.2%),
followed by squamous cell carcinoma (36 patients; 41.9%),
while only 5 cases (5.8%) of the small cell carcinoma, 3 cases
(3.5%) of the large cell carcinoma and 4 cases (4.7%) of the
undifferentiated carcinoma were diagnosed by CT guided
biopsy.
Supraclavicular lymph node biopsy was performed in 2
cases (0.5% of all cases), 1 of these cases proved to be
Figure 3 Smoking status distribution in males and females.
Figure 4 Incidence of different histopathological cell types in
smokers and in non-smokers.
Figure 5 Percentages of different clinical presentations.
Figure 6 Radiological ﬁndings of bronchogenic carcinoma.
Figure 7 Methods of diagnosis and their percentages.
Figure 8 Percentage of different pathologic cell types in this
study.
Figure 9 Distribution of histopathologic cell type in males and
females.
710 Y.M. Akl et al.squamous cell carcinoma, while other case was undifferenti-
ated carcinoma. Pleural ﬂuid cytology was positive in 9 cases
(2.2% of all cases), 3 cases were adenocarcinoma, 4 cases were
large cell carcinoma and 2 cases were squamous cell
carcinoma.
Thoracoscopy was the diagnostic procedure in 15 cases
(3.7% of all cases), 60% of them were adenocarcinoma,
13.3% were squamous cell carcinoma and 20% were undiffer-
entiated carcinoma.
Open biopsy was performed in l7cases (4.2% of all cases),
as regards the histologic cell type, that most cases were adeno-
carcinoma (52.9%) followed by squamous cell carcinoma
(23.5%).
In our study the most common histopathological cell type
was squamous cell carcinoma (37.4%), followed by adenocar-
cinoma (29.5%), small cell carcinoma (14.9%), large cell
Clinico-pathological proﬁle of bronchogenic carcinoma cases 711carcinoma (7.2%) and undifferentiated carcinoma (11.1%)
(Fig. 8).
In the cell type distribution reported by Radzikowska,
squamous cell carcinoma had the highest cell type incidence
(52.1%) followed by small cell carcinoma (20.8%) while
adenocarcinoma represented only 11.3% of the cases [11].
According to Shetty et al., study, squamous cell carcinoma
also presented 44.5% of cases followed by adenocarcinoma
(18.5%) and small cell carcinoma (17.2%) [15].
In another study by Rawat et al., they reported that 44.8%
of cases were squamous cell carcinoma followed by adenocar-
cinoma (19.7%) and small cell carcinoma (16.75%) [12].
In our study the incidence of squamous cell carcinoma
(37.4%) is less than that reported in a previous study and close
to percentage reported in study by Lam et al., (39%) [17].
The incidence of adenocarcinoma in our study (29.5%) is
higher than that reported in other studies 11.3%, 18.5% and
19.7% by Radzikowska et al. [11], Shetty et al. [15] and Rawat
et al. [12], respectively.
There was a shift in the incidence of squamous cell
carcinoma and adenocarcinoma, up to the late 1980s,
squamous cell carcinoma was the most common subtype,
which was then surpassed by adenocarcinoma. In recent years
adenocarcinoma is the most common histologic subtype of
lung cancer in most countries, accounting for almost half of
all lung cancers [18].
The shift in the incidence of squamous cell carcinoma and
adenocarcinoma may be associated with the switch from
non-ﬁltered to ﬁltered cigarettes, the depth of inhalation had
been altered [19].
In particular, smoke from unﬁltered strong cigarettes may
be shallowly inhaled, resulting in chemical carcinogen deposi-
tion centrally in the bronchial area and giving rise to squamous
cell carcinomas. Smoke from ﬁltered milder cigarettes may be
more deeply inhaled, resulting in carcinogen deposition more
peripherally and giving rise to adenocarcinomas. Reducing
the nicotine content may also promote deeper inhalation as
smokers attempt to compensate [20]. The changes in cigarette
composition reduced the yield of carcinogenic polycyclic
aromatic hydrocarbons (PAHs), inducers of squamous cell
carcinomas, while increasing the yields of carcinogenic
tobacco-speciﬁc N-nitrosamines (TSNAs), inducers of adeno-
carcinomas [21].
Other possible explanations that the increasing use of
mucin stains and immunocytochemical staining for antibodies
to CEA has contributed to enhanced recognition of adenocar-
cinomas [15].
These factors have contributed to the emerging predomi-
nance of adenocarcinoma in the lung cancer rates.
Fig. 9 shows that adenocarcinoma was the predominant
type (54.2%) in females followed by small cell carcinoma
(16.7%) and squamous cell carcinoma (13.9%). In males the
predominant type was squamous cell carcinoma (42.5%)
followed by adenocarcinoma (14.5%).
The criteria of inoperability in our cases included: X-ray
ﬁnding of chest wall invasion, ﬁnding of bilateral hilar or
mediastinal enlargement suggestive of lymph node involve-
ment, pleural effusion, mediastinal invasion and signs of vital
structures involvement, presence of extrathoracic metastasis,
bronchoscopic ﬁnding as vocal cord paralysis and tracheal or
carinal involvement and the presence of supraclavicular lymph
nodes metastasis.The high percentage of inoperable cases in our study may
be attributed to that some of the cases were misdiagnosed as
tuberculosis and treated by anti-tuberculous treatment at other
centers and after long time, the patients were referred to our
chest department, thereby causing a delay in diagnosis, the
smokers often explain any cough they experience as smoker’s
cough and this wrong belief may mask presence of tumor for
a long time before diagnosis and thus delay diagnosis until
the disease is at a more advanced. Lack of diagnostic facilities
at peripheral health centers could be another cause for delay in
diagnosis of bronchogenic carcinoma.
Conclusion
We can conclude from the study:
1. In this work, the highest incidence of bronchogenic
carcinoma was in the sixth and seventh decades of life.
The incidence declined before the age of 40 years and after
the age of 70 years.
2. Smoking still remains the major risk factor in the pathogen-
esis of bronchogenic carcinoma.
3. On histological examination, squamous cell carcinoma was
relatively more frequent than any other tumor type
followed by adenocarcinoma and then by small cell
carcinoma.
4. In all cell types of bronchogenic carcinoma, the mass lesion
was the major radiological ﬁnding and the majority of cases
were diagnosed by ﬁbro-optic bronchoscopy.
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